Significant Ownership of Alta Partners LLC

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Alta Partners LLC focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Steven Cohen - Steven Cohen, Managing Member
Manager location
Old Brookville, NY

Follow Filing Activity

Follow Alta Partners LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Significant Ownership of Alta Partners LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMTOF Femto Technologies Inc. Common Shares 14% $175,660 -$15,000 117,107 -7.9% Alta Partners LLC 04 Sep 2025
BHAT Blue Hat Interactive Entertainment Technology Ordinary Shares, par value $0.000005 per share 9.9% $12,330 308,253 Alta Partners LLC 24 Mar 2026
FOXX Foxx Development Holdings Inc. Common Stock, par value $0.0001 per share 9.8% $3,211,144 739,895 Alta Partners LLC 30 Jan 2025
ONFO Onfolio Holdings, Inc Common Stock 9.7% $674,603 630,470 0% Alta Partners LLC 14 Nov 2025
RMSG Real Messenger Corp Class A ordinary shares, par value $0.0001 per share 8.5% $2,732,975 +$1,927,568 1,012,213 +239% Alta Partners LLC 05 May 2026
COCHW Envoy Medical, Inc. Class A Common Stock 8.3% $97,207 1,944,139 Alta Partners LLC 20 Aug 2025
BRTX BioRestorative Therapies, Inc. Common Stock, $0.0001 par value 7.7% $2,162,467 1,787,163 Alta Partners LLC 13 Feb 2026
SWAG Stran & Company, Inc. Common stock, $0.0001 par value per share 7.6% $2,508,348 +$858,003 1,511,053 +52% Alta Partners LLC 29 Jan 2026
ABLV Able View Global Inc. Class B ordinary Shares, par value U.S. $0.0001 per share 7.6% $1,777,484 2,019,868 Alta Partners LLC 01 Dec 2025
OXUS Borealis Foods Inc. Class A ordinary shares, $0.0001 par value 6.3% 1,435,364 Alta Partners LLC 27 Feb 2026
BSLK Bolt Projects Holdings, Inc. Common Stock, par value $0.0001 per share 5.6% $40,322 161,290 Alta Partners LLC 28 Aug 2025
BCG Binah Capital Group, Inc. Common Stock, par value $0.0001 per share 5.5% $1,698,408 970,519 Alta Partners LLC 27 Feb 2025
CISS C3is Inc. Common Stock, par value $0.01 per share 5.2% $80,893 56,176 Alta Partners LLC 27 Feb 2026
BDMD Baird Medical Investment Holdings Ltd Common Stock, par value $0.0001 per share 5.1% $3,512,263 1,995,604 Alta Partners LLC 05 May 2026
QTIH QT IMAGING HOLDINGS, INC. Common Stock, par value $0.0001 per share 4.3% $1,184,444 -$2,535,718 540,842 -68% Alta Partners LLC 05 May 2026
BSLK Bolt Projects Holdings, Inc. Common Stock, par value $0.0001 per share 2.3% $187,953 48,819 Alta Partners LLC 30 Sep 2025
AEON AEON Biopharma, Inc. Common Stock 2.1% $192,400 -$259,078 249,870 -57% Alta Partners LLC 30 Sep 2025
VSEE VSee Health, Inc. Common Stock, $0.0001 par value per share 2% $308,332 -$511,064 833,331 -62% Alta Partners, LLC 31 Dec 2025
VWAV VisionWave Holdings, Inc. Common Stock 1.8% $2,829,487 -$12,104,270 281,541 -81% Alta Partners LLC 01 Jan 2026
CEAD CEA Industries Inc. Common Stock 0.1% 38,180 -33% Alta Partners LLC 30 Sep 2025

Schedules 13D/G Reported by Alta Partners LLC:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .